Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study
暂无分享,去创建一个
C. Obasaju | D. Richards | L. Wilfong | L. Asmar | C. Becerra | R. Hozak | S. Myrand | S. Nicol | P. Kuefler | K. Boehm | J. Gill | Luping Zhao | F. Zhan | B. Mullaney | R. Gersh